EP0650725A1 — Compositions containing salts of L-2-oxothiazolidine-4-carboxylic acid and their use for stimulating intracellular glutathione
Assigned to Free Radical Sciences Corp · Expires 1995-05-03 · 31y expired
What this patent protects
The composition comprises salt of L-2-oxothiazolidine-4-carboxylic acid. The salt may include at least one cation chosen from sodium; potassium; magnesium, calcium, iron; zinc; copper; calcium; selenium; manganese; and molybdenum for administration of the cation to a patient, for…
USPTO Abstract
The composition comprises salt of L-2-oxothiazolidine-4-carboxylic acid. The salt may include at least one cation chosen from sodium; potassium; magnesium, calcium, iron; zinc; copper; calcium; selenium; manganese; and molybdenum for administration of the cation to a patient, for example, for treatment of osteoporosis, malnutrition, dermatological dysfunction, or glucose intolerance.
Drugs covered by this patent
- Triferic (FERRIC PYROPHOSPHATE CITRATE) · Rockwell Medical Inc
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.